Advanced search
Publication Cover
OncoTargets and Therapy Volume 9, 2016 - Issue
Submit an article Journal homepage
69
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

Stefan Wittke1 University of Applied Sciences Bremerhaven, Faculty of Biotechnology Bremerhaven, Bochum, GermanyCorrespondence[email protected]
,
Susann Baxmann2 Ruhr-Plasma-Centre GmbH, Bochum, Germany
,
Dirk Fahlenkamp3 Department of Urology, Zeisigwald Bethanien Hospital, Chemnitz, Germany
&
Stephan T Kiessig2 Ruhr-Plasma-Centre GmbH, Bochum, Germany
Pages 523-537 | Published online: 27 Jan 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Behjatolah Monzavi-Karbassi, Fariba Jousheghany & Thomas Kieber-Emmons. (2016) Tumor-associated Glycans and Tregs in Immunogenicity of an Autologous Cell-based Vaccine. Immunological Investigations 45:8, pages 746-758.
Read now

Articles from other publishers (9)

Ángel de Jesús Jiménez-Chávez & Leticia Moreno-Fierros. (2022) Nonenveloped Virus-Like Particles: A Promising Antigen-Delivery Strategy for the Induction of Antitumor Immune Responses. Nano LIFE 12:04.
Crossref
Le Qu, Ding Wu, Haowei He, Xiaofeng Xu & Cheng Chen. 2020. Evolving Trends in Kidney Cancer. Evolving Trends in Kidney Cancer.
Qing Kay Li, Christian P. Pavlovich, Hui Zhang, Christopher R. Kinsinger & Daniel W. Chan. (2019) Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers. Seminars in Cancer Biology 55, pages 8-15.
Crossref
Christopher A. Parks, Kalli R. HenningKevin D. PavelkoMichael J. HansenVirginia P. Van KeulenBrendan K. ReedJennifer D. StoneAdam G. SchrumDiana GilDavid M. KranzAndrew J. BordnerMichael A. Barry & Larry R. Pease. (2019) Breaking tolerance with engineered class I antigen-presenting molecules. Proceedings of the National Academy of Sciences 116:8, pages 3136-3145.
Crossref
Ren-You Pan, Wen-Hung Chung, Mu-Tzu Chu, Shu-Jen Chen, Hua-Chien Chen, Lei Zheng & Shuen-Iu Hung. (2018) Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. Journal of Immunology Research 2018, pages 1-9.
Crossref
Sruthi Ravindranathan, Khue G. Nguyen, Samantha L. Kurtz, Haven N. Frazier, Sean G. Smith, Bhanu prasanth Koppolu, Narasimhan Rajaram & David A. Zaharoff. (2018) Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines. Breast Cancer Research 20:1.
Crossref
Sarah A. Hayes, Stephen Clarke, Nick Pavlakis & Viive M. Howell. (2018) The role of proteomics in the age of immunotherapies. Mammalian Genome 29:11-12, pages 757-769.
Crossref
Anton A. Pushkin, Yuriy E. Burda, Aleksandr A. Sevast’yanov, Vladimir F. Kulikovskiy, Svetlana Yu. Burda, Polina A. Golubinskaya, Alina K. Zvyagina & Natal’ya V. Kulyushina. (2018) Renal cell carcinoma drug and cell therapy: today and tomorrow. Research Results in Pharmacology 4:1, pages 17-25.
Crossref
Yang Hyun ChoMyung Soo KimHo Seok ChungEu Chang Hwang. (2017) Novel immunotherapy in metastatic renal cell carcinoma. Investigative and Clinical Urology 58:4, pages 220.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.